Target intelligence / Profile preview

PIK3CD antisense RNA 1 (PIK3CD-AS1)

Target
PIK3CD-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

PIK3CD antisense RNA 1 (PIK3CD-AS1) is a long non-coding RNA (lncRNA) located antisense to the PIK3CD gene. It does not encode a protein but is involved in the regulation of PIK3CD gene expression, likely through mechanisms involving transcriptional interference or chromatin modification. PIK3CD-AS1 shows tissue- and development-specific expression, particularly in the brain, and its expression is increased in cell models and tissues from patients with schizophrenia, suggesting a role in neurodevelopment and psychiatric disease[1][2][4]. Current research focuses on its potential regulatory function on PIK3CD and related pathways, but its direct molecular mechanisms, therapeutic potential, and biomarker value remain uncharacterized. There is no reported interaction with drugs, nor is there evidence it functions as a classical therapeutic target such as a receptor, enzyme, or transporter[1][2][5]. Key evidence suggests that PIK3CD-AS1 is not a conventional drug target but rather a regulatory lncRNA with possible roles in disease association and gene expression regulation[1][2][4][5].

Other names
C1orf200Putative uncharacterized protein PIK3CD-AS1PIK3CD antisense gene protein 1
02

Biological functions

Regulation of gene expressionPossible regulation of PIK3CD transcriptionImplicated in cell proliferation, apoptosis, and migrationOther
03

Disease associations

Neurodevelopmental disorders (notably schizophrenia)Potential cancer association (but more evidence for PIK3CD-AS2 than AS1)Other

Beyond the preview

Go deeper on PIK3CD antisense RNA 1 (PIK3CD-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIK3CD antisense RNA 1 (PIK3CD-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call